Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

Details for Australian Patent Application No. 2009226151 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Kramer, Bryan A.; Sadeque, Abu J.M.; Zou, Ning; Tran, Thuy-Anh; Vallar, Pureza; Shin, Young-Jun; Chen, Weichao; Shyfryna, Hanna L.

Agent FB Rice

Pub. Number AU-A-2009226151

PCT Pub. Number WO2009/117095

Priority 61/123,621 09.04.08 US; 61/209,453 06.03.09 US; 61/207,220 09.02.09 US; 61/069,857 18.03.08 US

Filing date 17 March 2009

Wipo publication date 24 September 2009

International Classifications

C07C 271/08 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/27 (2006.01)

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 275/18 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/117095 Priority application(s): WO2009/117095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226152-Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

2009226141-Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase